1. Home
  2. ADTN vs MDXG Comparison

ADTN vs MDXG Comparison

Compare ADTN & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$15.76

Market Cap

1.2B

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.63

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
MDXG
Founded
1985
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
530.2M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
ADTN
MDXG
Price
$15.76
$3.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$15.50
$9.00
AVG Volume (30 Days)
2.3M
1.7M
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
14.29
EPS
N/A
N/A
Revenue
$1,083,807,000.00
$418,630,000.00
Revenue This Year
$11.09
N/A
Revenue Next Year
$8.47
$13.02
P/E Ratio
N/A
N/A
Revenue Growth
17.46
19.99
52 Week Low
$7.11
$3.03
52 Week High
$18.69
$7.99

Technical Indicators

Market Signals
Indicator
ADTN
MDXG
Relative Strength Index (RSI) 53.48 49.42
Support Level $8.45 $3.45
Resistance Level $16.28 $7.39
Average True Range (ATR) 0.87 0.12
MACD -0.19 0.04
Stochastic Oscillator 77.06 51.43

Price Performance

Historical Comparison
ADTN
MDXG

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: